Annual Revenue
$31.09 M
+$1.73 M+5.88%
31 December 2023
Summary:
Cytosorbents annual revenue is currently $31.09 million, with the most recent change of +$1.73 million (+5.88%) on 31 December 2023. During the last 3 years, it has fallen by -$8.37 million (-21.21%). CTSO annual revenue is now -22.50% below its all-time high of $40.11 million, reached on 31 December 2021.CTSO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$8.61 M
-$229.00 K-2.59%
30 September 2024
Summary:
Cytosorbents quarterly revenue is currently $8.61 million, with the most recent change of -$229.00 thousand (-2.59%) on 30 September 2024. Over the past year, it has increased by +$858.80 thousand (+11.08%). CTSO quarterly revenue is now -25.30% below its all-time high of $11.53 million, reached on 31 December 2020.CTSO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$33.79 M
+$858.80 K+2.61%
30 September 2024
Summary:
Cytosorbents TTM revenue is currently $33.79 million, with the most recent change of +$858.80 thousand (+2.61%) on 30 September 2024. Over the past year, it has increased by +$2.41 million (+7.69%). CTSO TTM revenue is now -21.93% below its all-time high of $43.28 million, reached on 30 June 2021.CTSO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.9% | +11.1% | +7.7% |
| 3 y3 years | -21.2% | -3.3% | -19.4% |
| 5 y5 years | +53.5% | +50.4% | +56.3% |
CTSO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -22.5% | +5.9% | -11.2% | +33.3% | -19.4% | +15.2% |
| 5 y | 5 years | -22.5% | +53.5% | -25.3% | +50.4% | -21.9% | +56.3% |
| alltime | all time | -22.5% | >+9999.0% | -25.3% | >+9999.0% | -21.9% | >+9999.0% |
Cytosorbents Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.61 M(-2.6%) | $33.79 M(+2.6%) |
| June 2024 | - | $8.84 M(-1.6%) | $32.93 M(+2.4%) |
| Mar 2024 | - | $8.99 M(+22.3%) | $32.16 M(+3.5%) |
| Dec 2023 | $31.09 M(+5.9%) | $7.35 M(-5.2%) | $31.08 M(-0.9%) |
| Sept 2023 | - | $7.75 M(-3.9%) | $31.38 M(+4.3%) |
| June 2023 | - | $8.07 M(+2.1%) | $30.09 M(+2.5%) |
| Mar 2023 | - | $7.91 M(+3.5%) | $29.35 M(-0.0%) |
| Dec 2022 | $29.36 M(-26.8%) | $7.64 M(+18.2%) | $29.36 M(-6.5%) |
| Sept 2022 | - | $6.46 M(-11.8%) | $31.42 M(-7.2%) |
| June 2022 | - | $7.33 M(-7.5%) | $33.85 M(-10.6%) |
| Mar 2022 | - | $7.92 M(-18.3%) | $37.89 M(-5.5%) |
| Dec 2021 | $40.11 M(+1.7%) | $9.70 M(+8.9%) | $40.11 M(-4.4%) |
| Sept 2021 | - | $8.90 M(-21.7%) | $41.94 M(-3.1%) |
| June 2021 | - | $11.37 M(+12.0%) | $43.28 M(+4.5%) |
| Mar 2021 | - | $10.14 M(-12.0%) | $41.44 M(+5.0%) |
| Dec 2020 | $39.45 M(+73.3%) | $11.53 M(+12.5%) | $39.45 M(+14.2%) |
| Sept 2020 | - | $10.25 M(+7.6%) | $34.53 M(+15.0%) |
| June 2020 | - | $9.52 M(+16.7%) | $30.02 M(+13.9%) |
| Mar 2020 | - | $8.16 M(+23.4%) | $26.35 M(+15.7%) |
| Dec 2019 | $22.77 M(+12.4%) | $6.61 M(+15.4%) | $22.77 M(+5.3%) |
| Sept 2019 | - | $5.73 M(-2.1%) | $21.63 M(+3.0%) |
| June 2019 | - | $5.85 M(+27.8%) | $21.00 M(+3.0%) |
| Mar 2019 | - | $4.58 M(-16.3%) | $20.40 M(+0.7%) |
| Dec 2018 | $20.25 M(+51.3%) | $5.47 M(+7.2%) | $20.25 M(+6.2%) |
| Sept 2018 | - | $5.10 M(-2.7%) | $19.08 M(+9.5%) |
| June 2018 | - | $5.25 M(+18.3%) | $17.42 M(+14.5%) |
| Mar 2018 | - | $4.43 M(+3.2%) | $15.22 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $13.38 M(+63.1%) | $4.30 M(+24.6%) | $13.38 M(+14.4%) |
| Sept 2017 | - | $3.45 M(+13.4%) | $11.70 M(+12.6%) |
| June 2017 | - | $3.04 M(+17.1%) | $10.39 M(+12.9%) |
| Mar 2017 | - | $2.60 M(-0.6%) | $9.20 M(+12.2%) |
| Dec 2016 | $8.21 M(+102.3%) | $2.61 M(+21.9%) | $8.21 M(+15.8%) |
| Sept 2016 | - | $2.14 M(+15.7%) | $7.09 M(+17.8%) |
| June 2016 | - | $1.85 M(+16.0%) | $6.02 M(+21.6%) |
| Mar 2016 | - | $1.60 M(+6.8%) | $4.95 M(+22.0%) |
| Dec 2015 | $4.06 M(+29.0%) | $1.50 M(+39.6%) | $4.06 M(+18.1%) |
| Sept 2015 | - | $1.07 M(+36.6%) | $3.43 M(+1.1%) |
| June 2015 | - | $784.30 K(+11.3%) | $3.40 M(+3.6%) |
| Mar 2015 | - | $704.50 K(-19.4%) | $3.28 M(+4.2%) |
| Dec 2014 | $3.14 M(+282.6%) | $873.70 K(-15.5%) | $3.14 M(+21.6%) |
| Sept 2014 | - | $1.03 M(+55.4%) | $2.59 M(+47.3%) |
| June 2014 | - | $665.70 K(+16.6%) | $1.75 M(+44.2%) |
| Mar 2014 | - | $570.90 K(+81.7%) | $1.22 M(+48.0%) |
| Dec 2013 | $821.80 K(+442.1%) | $314.20 K(+54.3%) | $821.90 K(+38.0%) |
| Sept 2013 | - | $203.60 K(+59.1%) | $595.70 K(+46.8%) |
| June 2013 | - | $128.00 K(-27.3%) | $405.80 K(+30.6%) |
| Mar 2013 | - | $176.10 K(+100.1%) | $310.80 K(+105.0%) |
| Dec 2012 | $151.60 K(+319.9%) | $88.00 K(+542.3%) | $151.60 K(+52.1%) |
| Sept 2012 | - | $13.70 K(-58.5%) | $99.70 K(+15.9%) |
| June 2012 | - | $33.00 K(+95.3%) | $86.00 K(+62.3%) |
| Mar 2012 | - | $16.90 K(-53.2%) | $53.00 K(+46.8%) |
| Dec 2011 | $36.10 K | $36.10 K(+780.5%) | $36.10 K(+284.0%) |
| Feb 2006 | - | $4100.00(-22.6%) | $9400.00(+77.4%) |
| Nov 2005 | - | $5300.00 | $5300.00 |
FAQ
- What is Cytosorbents annual revenue?
- What is the all time high annual revenue for Cytosorbents?
- What is Cytosorbents annual revenue year-on-year change?
- What is Cytosorbents quarterly revenue?
- What is the all time high quarterly revenue for Cytosorbents?
- What is Cytosorbents quarterly revenue year-on-year change?
- What is Cytosorbents TTM revenue?
- What is the all time high TTM revenue for Cytosorbents?
- What is Cytosorbents TTM revenue year-on-year change?
What is Cytosorbents annual revenue?
The current annual revenue of CTSO is $31.09 M
What is the all time high annual revenue for Cytosorbents?
Cytosorbents all-time high annual revenue is $40.11 M
What is Cytosorbents annual revenue year-on-year change?
Over the past year, CTSO annual revenue has changed by +$1.73 M (+5.88%)
What is Cytosorbents quarterly revenue?
The current quarterly revenue of CTSO is $8.61 M
What is the all time high quarterly revenue for Cytosorbents?
Cytosorbents all-time high quarterly revenue is $11.53 M
What is Cytosorbents quarterly revenue year-on-year change?
Over the past year, CTSO quarterly revenue has changed by +$858.80 K (+11.08%)
What is Cytosorbents TTM revenue?
The current TTM revenue of CTSO is $33.79 M
What is the all time high TTM revenue for Cytosorbents?
Cytosorbents all-time high TTM revenue is $43.28 M
What is Cytosorbents TTM revenue year-on-year change?
Over the past year, CTSO TTM revenue has changed by +$2.41 M (+7.69%)